Fosun Pharma For Profit
上海复星医药集团（“复星医药”，股票代码：600196.SH，02196.HK）成立于1994 年，是一家植根中国、创新驱动的全球化医药健康产业集团，直接运营的业务包括制药、医疗器械与医学诊断、医疗健康服务，并通过参股国药控股覆盖到医药商业领域。
%20.jpg)
Funding Status:
M&A
Industry:
Longevity Biomarkers
Estimated Revenue:
RMB 43.952 billion
Number Of Exists:
11
Headquarters:
Shanghai, Shanghai, China
Total Funding:
53487377
Last Funding Date:
2023-06-06
Last Funding Type:
Debt Financing
Investor Type:
Venture Capital
Employee Number:
10001+
Investors Number:
1
Founded Date:
1994-01-01